Cm Management, LLC Edesa Biotech, Inc. Transaction History

Cm Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$0.63 - $0.99 $26,839 - $42,175	42,602 Added 11.36%	417,602 $263,000
Q2 2023 Aug 04, 2023	BUY	$0.77 - $1.16 $38,500 - $57,999	50,000 Added 15.38%	375,000 $304,000
Q1 2023 May 08, 2023	BUY	$0.91 - $2.63 $11,126 - $32,157	12,227 Added 3.91%	325,000 $296,000
Q4 2022 Feb 09, 2023	BUY	$0.8 - $8.05 $50,218 - $505,322	62,773 Added 25.11%	312,773 $676,000
Q3 2022 Nov 04, 2022	BUY	$1.39 - $9.94 $347,500 - $2.49 Million	250,000 New	250,000 $230,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $28.6M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.